Cargando…
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
Autores principales: | Jamsen, Kris M, Duffull, Stephen B, Tarning, Joel, Lindegardh, Niklas, White, Nicholas J, Simpson, Julie A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155838/ https://www.ncbi.nlm.nih.gov/pubmed/21722356 http://dx.doi.org/10.1186/1475-2875-10-181 |
Ejemplares similares
-
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2012) -
Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009) -
Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012) -
A robust design for identification of the Parasite Clearance Estimator
por: Jamsen, Kris M, et al.
Publicado: (2013) -
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
por: McGready, Rose, et al.
Publicado: (2012)